Title
Category
Credits
Event date
Cost
The Age of Disease Modification in Alzheimer’s Disease: A Grand Rounds Series on the Practical Implementation of Amyloid Targeting Therapies into Clinical Practice
  • 1.00 AMA PRA Category 1 Credit™
06/19/2025
$0.00
Program DescriptionFor the first time in the history of AD management, a class of therapy designed to alter the disease course for patients is finally a reality in the form of anti-amyloid beta monoclonal antibodies (anti-Aβ mAbs). And while this development represents a monumental shift in the treatment of this progressive disease, it unlocks a whole host of new challenges for clinicians in the form of significant adjustment of practice norms.